摘要:
Substituted N-arylmethyl and heterocyclylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines, pharmaceutical compositions containing them and methods for a) effecting c-GMP-phosphodiesterase inhibition, b) treating heart failure and/or hypertension, c) reversing or reducing nitrate-induced tolerance and d) treating angina pectoris, congestive heart disease and myocardial infarction utilizing them.
摘要:
The present invention is related to compounds which inhibit pancreatic cholesterol esterase. The compounds have formula (I), wherein R1 is H or C¿1-6? alkyl; R?2¿ is H or C¿1-6? alkyl; R?3¿ is H or C¿1-6? alkyl; X is CHR?6¿, S or O; R6 is H or C¿1-6? alkyl; R?4¿ is a hydrophobic moiety; and pharmaceutically acceptable salts thereof.
摘要:
Disclosed are compounds, compositions, and methods for inhibiting interleukin-1β protease activity, having formula (A), wherein Y = (a) or (b) or (c), Z = various bicyclic lactams with a bridgehead nitrogen.
摘要:
Disclosed are compounds, compositions and methods for inhibiting interleukin-1β protease activity, the compounds having formula (A) described herein.
摘要:
6-Aryl pyrazolo[3,4-d]pyrimidin-4-one derivatives, pharmaceutical compositions containing them and methods for effecting c-GMP-phosphodiesterase inhibition and for treating heart failure and/or hypertension.
摘要:
Substituted N-cycloalkylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines, pharmaceutical compositions containing them and methods for a) effecting c-GMP-phosphodiesterase inhibition, b) treating heart failure and/or hypertension, c) reversing or reducing nitrate-induced tolerance, and d) treating angina pectoris, congestive heart disease and myocardial infarction utilizing them.
摘要:
2-(2,3,5,6-Tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides, pharmaceutical compositions containing them and methods for the treatment of degenerative diseases utilizing them.